Clinical trial
Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage…
NCT00098995 · Peter MacCallum Cancer Centre, Australia, Other · Completed
Key facts
| NCT number | NCT00098995 |
|---|---|
| Title | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer |
| Official title | A Phase I Study Of Tirapazamine In Combination With Radiation And Weekly Cisplatin In Patients With Locally Advanced Cervical Cancer |
| Lead sponsor | Peter MacCallum Cancer Centre, Australia, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, tirapazamine, brachytherapy, radiation therapy |
| Enrollment | 22 |
| Start date | Dec 1, 2004 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Dec 9, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | Australia, Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: